What is Groundwork BioAg?
Groundwork BioAg is a global bioagriculture company dedicated to enhancing commercial agriculture through the power of mycorrhizal fungi. By improving crop productivity, sustainability, and profitability, the company is a key player in expanding regenerative agriculture. Their innovative approach leverages natural biological processes to create more resilient and environmentally sound farming solutions, positioning them at the forefront of agricultural technology.
How much funding has Groundwork BioAg raised?
Groundwork BioAg has raised a total of $29M across 2 funding rounds:
Unspecified
$11M
Series B
$18M
Unspecified (2021): $11M with participation from Future Foodways, ProDelta Holding, and Ibex Investors
Series B (2022): $18M led by Middleland Capital, Climate Innovation Capital, HSBC Global Asset Management, ICV Ventures, and BASF Venture Capital
Key Investors in Groundwork BioAg
Middleland Capital
Middleland Capital is a thematic venture capital fund focused on catalyzing global change in the food and health sectors, specializing in innovative foodtech and agtech.
Climate Innovation Capital
Climate Innovation Capital focuses on finding, funding, and growing commercial innovations that aim to decarbonize the economy, investing in climate technology deployment.
HSBC Global Asset Management
HSBC Global Asset Management is a global asset manager providing a wide range of investment solutions.
What's next for Groundwork BioAg?
The substantial enterprise-level funding indicates Groundwork BioAg is poised for significant scaling and market expansion. This capital injection will likely fuel further research and development into novel fungal-based agricultural solutions, as well as support broader commercialization efforts. The company's focus on sustainability and profitability aligns with growing global demand for eco-friendly agricultural inputs, suggesting a strong trajectory for future growth and impact in the agtech landscape.
See full Groundwork BioAg company page
